Legal & General Group
EPIX

Legal & General Group’s ESSA Pharma EPIX Stock Holding History

Legal & General Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,124
Closed -$38K – 3563
2022
Q1 		$38K Hold
6,124
– – ﹤0.01% 3056
2021
Q4 		$87K Buy
6,124
+1,003
+20% +$11.2K ﹤0.01% 2933
2021
Q3 		$41K Buy
5,121
+4,197
+454% +$66.7K ﹤0.01% 3029
2021
Q2 		$26K Buy
+924
New +$26.9K ﹤0.01% 3191

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $24.2B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return